CARDIOVASCULAR MEDICINE

Clopidogrel reduces migraine with aura after transcatheter closure of persistent foramen ovale and atrial septal defects

P T Wilmshurst¹, S Nightingale¹, K P Walsh², W L Morrison³

¹ Royal Shrewsbury Hospital, Shrewsbury, UK
² Our Lady’s Hospital for Sick Children, Dublin, Republic of Ireland
³ The Cardiothoracic Centre, Liverpool, UK

Correspondence to:
Correspondence to:
Dr Peter T Wilmshurst
Royal Shrewsbury Hospital, Shrewsbury SY3 8XQ, UK; peter.wilmshurst{at}rsh.nhs.uk

Objective: To report the clinical events leading to alteration of an anticoagulation regimen for patients undergoing transcatheter closure of an atrial shunt and how this affected migraine symptoms after the closure procedure.

Method: Audit of a change of anticoagulant regimen.

Results: In the first few weeks after a closure procedure migraine frequency and severity increased despite treatment with aspirin for six months in 71 patients. Severe attacks of migraine with aura, including status migrainosus, in the first few weeks after transcatheter closure were terminated by addition of clopidogrel to aspirin treatment. Therefore, the anticoagulant regimen was changed with addition of clopidogrel for the first month after the closure procedure (90 procedures in 89 patients). Fewer patients had migraine with aura in the first month after transcatheter closure when taking the combination of clopidogrel and aspirin compared with aspirin alone (11 of 90 (12.2%) v 30 of 71 (42.3%), p < 0.001). Episodes of migraine with aura were more severe and more frequent in patients taking aspirin alone.

Conclusion: The combination of clopidogrel for four weeks and aspirin for six months is superior to aspirin alone for six months for preventing migraine with aura after transcatheter closure of an atrial shunt. This beneficial effect of a powerful inhibitor of platelet aggregation suggests that platelets may have a role in pathogenesis of migraine. This may be because of an effect on serotonin stores. Whether clopidogrel has a role in treatment of migraine in other clinical situations requires investigation.

Keywords: atrial septal defect; clopidogrel; migraine; persistent foramen ovale; transcatheter closure

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Reisman, M., Fuller, C. J. (2009). Is patent foramen ovale closure indicated for migraine?: Patent Foramen Ovale Closure for Migraine. Circ Cardiovasc Interv 2: 468-474 [Full Text]  
• Wilmshurst, P. (2009). The Effect of Persistent Foramen Ovale Closure on Migraine Remains an Enigma. J Am Coll Cardiol Intv 2: 114-115 [Full Text]  
• Rundek, T., Elkind, M. S.V., Di Tullio, M. R., Carrera, E., Jin, Z., Sacco, R. L., Homma, S. (2008). Patent Foramen Ovale and Migraine: A Cross-Sectional Study From the Northern Manhattan Study (NOMAS). Circulation 118: 1419-1424 [Abstract] [Full Text]  
• Dowson, A., Mullen, M. J., Peatfield, R., Muir, K., Khan, A. A., Wells, C., Lipscombe, S. L., Rees, T., De Giovanni, J. V., Morrison, W. L., Hildick-Smith, D., Elrington, G., Hillis, W. S., Malik, I. S., Rickards, A. (2008). Migraine Intervention With STARFlex Technology (MIST) Trial: A Prospective, Multicenter, Double-Blind, Sham-Controlled Trial to Evaluate the Effectiveness of Patent Foramen Ovale Closure With STARFlex Septal Repair Implant to Resolve Refractory Migraine Headache. Circulation 117: 1397-1404 [Abstract] [Full Text]  
• Carroll, J. D. (2008). Migraine Intervention With STARFlex Technology Trial: A Controversial Trial of Migraine and Patent Foramen Ovale Closure. Circulation 117: 1358-1360 [Full Text]  
• Lapergue, B., Rosso, C., Hadrane, L., Labreuche, J., Abboud, H., Brochet, E., Juliard, J. -M., Amarenco, P. (2006). Frequency of migraine attacks following stroke starts to decrease before PFO closure.. Neurology 67: 1099-1100 [Full Text]  

eLetters:

Read all eLetters

Clopidogrel and atrial shunt closure for migraine: why is migraine aggravated immediately?

Vinod K Gupta

Online, 13 Dec 2005 [Full text]